SEHK:1686
SEHK:1686IT

SUNeVision (SEHK:1686) Valuation Check as New Board Appointments Signal Potential Strategic Shift

SUNeVision Holdings (SEHK:1686) has just refreshed its leadership bench by adding technology executive Helen Lo as Executive Director and finance veteran Kenny Lam as Independent Non Executive Director, alongside a new Company Secretary, Noel Lok. See our latest analysis for SUNeVision Holdings. The leadership refresh lands at a tricky moment for the stock, with a 1 month share price return of negative 13.37 percent and a 90 day share price return of negative 25.30 percent, even though the...
SEHK:1093
SEHK:1093Pharmaceuticals

Will New Depression and Metabolic Trial Approvals Change CSPC Pharmaceutical Group's (SEHK:1093) Narrative?

In late 2025, CSPC Pharmaceutical Group announced multiple regulatory approvals in the U.S. and China to begin clinical trials for innovative therapies targeting major depressive disorder, obesity and overweight with comorbidities, and complement-mediated diseases such as IgA nephropathy. By advancing a 5-HT2A agonist without hallucination risk, a dual-biased GLP-1/GIP agonist, and an ultra-long-acting C5 siRNA, CSPC is pivoting its pipeline toward high-demand areas where existing treatment...
SEHK:1428
SEHK:1428Capital Markets

Evaluating Bright Smart Securities & Commodities Group (SEHK:1428) After Its Profit-Improving Half-Year Results

Bright Smart Securities & Commodities Group (SEHK:1428) just posted its half year results, with revenue broadly flat but net income and earnings per share edging higher, hinting at better cost discipline behind the scenes. See our latest analysis for Bright Smart Securities & Commodities Group. The half year earnings tweak the narrative for Bright Smart Securities & Commodities Group, with a 1 year total shareholder return of 247.35 percent still looking strong. At the same time, the 90 day...
SEHK:2628
SEHK:2628Insurance

Is China Life’s New Subsidiary Agreements Quietly Redefining Its Risk Strategy (SEHK:2628)?

China Life Insurance Company Limited recently held its Second Extraordinary General Meeting, where shareholders considered resolutions on investment and management agreements with several subsidiaries that shape how capital and operations are coordinated across the group. This focus on group-wide investment and management frameworks highlights how China Life Insurance may be refining internal collaboration to support its evolving product mix and risk profile. We’ll now examine how this...